Brian Corvese's Net Worth
$613 Thousand
Who is Brian Corvese?
Brian Corvese does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include AGENUS INC, MiNK Therapeutics, Inc., and Protagenic Therapeutics, Inc.\new.
SEC CIK
Brian Corvese's CIK is 0001393207
Past Insider Trading and Trends
2020 was Brian Corvese's most active year for acquiring shares with 6 total transactions. Brian Corvese's most active month to acquire stocks was the month of May. 2018 was Brian Corvese's most active year for disposing of shares, totalling 1 transactions. Brian Corvese's most active month to dispose stocks was the month of February. 2018 saw Brian Corvese paying a total of $211,875.00 for 79,996 shares, this is the most they've acquired in one year. In 2018 Brian Corvese cashed out on 21,220 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
AGENUS INC (AGEN) Snapshot price: $4.95
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
| +32.28% | 22.47K |
—
|
—
| 92.08K |
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 17
| |||
Form 4
| +43.55% | 21.12K |
—
|
—
| 69.61K |
Jun 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
∞
| 21.22K |
—
|
—
| 21.22K |
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
MiNK Therapeutics, Inc. (INKT) Snapshot price: $0.8291
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +5.69% | 21.8K |
$0.82 | $17,877.64 | 405.3K |
Sep 3
| |||
Form 4
| +4.92% | 17.97K |
$0.99 | $17,787.33 | 383.49K |
Jun 3
| |||
Form 4
| +5.43% | 18.82K |
$0.95 | $17,875.20 | 365.53K |
Mar 1
| |||
Form 4
| +5.22% | 17.19K |
$1.04 | $17,875.52 | 346.71K |
Dec 1
| |||
Form 4
| +3.86% | 12.24K |
$1.46 | $17,876.24 | 329.52K |
Sep 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
| +3.30% | 10.16K |
$1.76 | $17,876.32 | 317.5K |
Jun 1
| |||
Form 4
| +2.86% | 8.55K |
$2.09 | $17,875.77 | 307.35K |
Mar 1
| |||
Form 4
| +2.35% | 6.85K |
$2.61 | $17,875.89 | 298.8K |
Dec 1
| |||
Form 4
|
∞
| 13.65K |
$2.62 | $35,752.52 | 13.65K |
Sep 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Protagenic Therapeutics, Inc.\new (PTIX) Snapshot price: $0.7888
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 16
| |||
| No matching records found | |||||||||